Clinical trial · Interventional
Wearable Device and Self-Regulation Strategies to Promote Physical Activity Among Children With Cancer: A Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a clinical trial that tested whether a 12-week exercise program using smart wristbands and personalized goal-setting could help children with cancer become more active, feel more confident about exercising, and improve their quality of life. The study included 72 children and teenagers (ages 6-18) receiving cancer treatment at two hospitals in China. They were divided into two groups: Intervention group (33 children): Used a smart wristband to track daily steps, followed a personalized exercise plan, and received weekly guidance. Control group (39 children): Continued with usual care (no special exercise program). The main questions it aims to answer are: 1. Does the exercise program help children with cancer move more and sit less; 2. Can it boost their confidence to stay active and improve their physical and emotional well-being?
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control group (placebo) | Behavioral | — | UNRESOLVED |
| In-Hospital Program | Behavioral | — | UNRESOLVED |
| Post-Discharge Program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental group
- description
- Smart wristband to track daily steps, followed a personalized exercise plan, and received weekly guidance
- interventionNames
- Behavioral: In-Hospital Program
- Behavioral: Post-Discharge Program
- type
- PLACEBO_COMPARATOR
- label
- Control group
- description
- Routine health education
- interventionNames
- Behavioral: Control group (placebo)
Primary outcomes (1)
- measure
- physical activity
- timeFrame
- From enrollment to the end of treatment at 12 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age between 6 and 18 years old; * Children diagnosed with leukemia, lymphoma, or solid tumor confirmed by pathology or bone marrow examination; * Obtaining informed consent from the child and their guardian; * Approval from the attending physician for participation in physical activity interventions. Exclusion Criteria: * Children diagnosed with mental health disorders; * Individuals with severe physical disabilities incompatible with physical activity participation; * Cases involving metastasis to bone tissue that would restrict movement.
References
Publications (2)
- BACKGROUNDAtun R, Bhakta N, Denburg A, Frazier AL, Friedrich P, Gupta S, Lam CG, Ward ZJ, Yeh JM, Allemani C, Coleman MP, Di Carlo V, Loucaides E, Fitchett E, Girardi F, Horton SE, Bray F, Steliarova-Foucher E, Sullivan R, Aitken JF, Banavali S, Binagwaho A, Alcasabas P, Antillon F, Arora RS, Barr RD, Bouffet E, Challinor J, Fuentes-Alabi S, Gross T, Hagander L, Hoffman RI, Herrera C, Kutluk T, Marcus KJ, Moreira C, Pritchard-Jones K, Ramirez O, Renner L, Robison LL, Shalkow J, Sung L, Yeoh A, Rodriguez-Galindo C. Sustainable care for children with cancer: a Lancet Oncology Commission. Lancet Oncol. 2020 Apr;21(4):e185-e224. doi: 10.1016/S1470-2045(20)30022-X. PMID 32240612
- RESULTHudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, Green DM, Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013 Jun 12;309(22):2371-2381. doi: 10.1001/jama.2013.6296. PMID 23757085